Sharon Bio-Medicine informs outcome of board meeting

22 Jan 2013 Evaluate

Sharon Bio-Medicine has now informed that the board of directors at its meeting held on January 21, 2013, has resolved to convene an extra-ordinary general meeting to be held on February 16, 2013, for the approval of the shareholders on the said rollover of the existing FCCBs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×